{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "esgPopulated": false, "market": "kr_market", "longName": "Samjin Pharmaceuticals Co., Ltd.", "marketState": "PREPRE", "regularMarketPrice": 22550.0, "messageBoardId": "finmb_9461579", "exchange": "KSC", "shortName": "SamjinPharm", "exchangeTimezoneShortName": "KST", "exchangeTimezoneName": "Asia/Seoul", "regularMarketChangePercent": 0.66964287, "gmtOffSetMilliseconds": 32400000, "fiftyTwoWeekLowChange": 2560.0, "fiftyTwoWeekLowChangePercent": 0.12806404, "fiftyTwoWeekRange": "19990.0 - 28500.0", "fiftyTwoWeekHighChange": -5950.0, "fiftyTwoWeekHighChangePercent": -0.20877193, "fiftyTwoWeekLow": 19990.0, "fiftyTwoWeekHigh": 28500.0, "earningsTimestamp": 1675681140, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "firstTradeDateMilliseconds": 1127952000000, "priceHint": 2, "regularMarketChange": 150.0, "regularMarketTime": 1683873024, "regularMarketDayHigh": 22550.0, "regularMarketDayRange": "22300.0 - 22550.0", "regularMarketDayLow": 22300.0, "regularMarketVolume": 18385, "regularMarketPreviousClose": 22400.0, "bid": 22450.0, "ask": 22500.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KSE", "financialCurrency": "KRW", "regularMarketOpen": 22350.0, "averageDailyVolume3Month": 46428, "averageDailyVolume10Day": 25841, "sharesOutstanding": 13230900, "fiftyDayAverage": 22124.0, "fiftyDayAverageChange": 426.0, "fiftyDayAverageChangePercent": 0.019255107, "twoHundredDayAverage": 24364.75, "twoHundredDayAverageChange": -1814.75, "twoHundredDayAverageChangePercent": -0.074482605, "marketCap": 298356801536, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "symbol": "005500.KS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "121 Wausan Ro", "address2": "Mapo-gu Seogyo dong", "city": "Seoul", "zip": "04054", "country": "South Korea", "phone": "82 2 3140 0700", "fax": "82 2 392 5312", "website": "https://www.samjinpharm.co.kr", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer's disease, Parkinson's disease, and anti-viral disease. The company was founded in 1968 and is headquartered in Seoul, South Korea.", "fullTimeEmployees": 586, "companyOfficers": [{"maxAge": 1, "name": "Yong-Joo  Choi", "age": 55, "title": "CEO & Director", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}